Other Capital Market Information | 6 May 2019 12:09
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para.
1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052
06.05.2019 / 12:09
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
- Share buy-back - 8th Interim Report
In the period from April 29, 2019 until and including May 03, 2019, a total
of 111,494 shares were repurchased within the framework of the share buy-
back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care') announced on March 11, 2019 pursuant to Art. 5 para. 1 lit. a) of
Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU)
2016/1052.
The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:
Day of repurchase Aggregated volume in Weighted average share
number of shares price
in EUR
29.04.2019 413 73.3889
30.04.2019 61,033 74.6422
02.05.2019 49,803 75.4376
03.05.2019 245 75.3642
The total volume of shares repurchased within the framework of this share
buy-back in the period from March 12, 2019 until and including May 03, 2019
therefore amounts to 3,673,262 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., May 06, 2019
---------------------------------------------------------------------------
06.05.2019 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
End of News DGAP News Service